Document is current
Any future updates will be listed below
-
Authors
Mollamohammadi-Omran, Setareh https://orcid.org/0009-0003-9422-3554
Nikbakht, Hossein-Ali https://orcid.org/0000-0002-8556-431X
Sedighi, Saman https://orcid.org/0000-0002-6568-5974
Javanian, Mostafa https://orcid.org/0000-0002-2771-4578
Babapour-darzi, Rahman https://orcid.org/0009-0001-6342-1027
Ghasemi-Khoshrodi, Maryam https://orcid.org/0009-0006-7356-9144
Mouodi, Simin https://orcid.org/0000-0001-7868-9360
- License Information
-
More Information
Article History
Received: 29 March 2025
Accepted: 5 February 2026
First Online: 20 February 2026
Declarations
:
: All procedures performed in this study were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The research protocol has been approved by the ethics committee of Babol University of Medical Sciences with the identification code (MUBABOL.HRI.REC.1401.107). At baseline vaccination, a trained vaccinator (health service provider) informed the participants (or their parent or legal guardian in the case of children under 18) about the advantages, and also probable complications following immunization, and a written informed consent was obtained. A copy of this form is available for review by the Editor-in-Chief of this journal.
: At baseline vaccination, the participants or their proxies provided an informed consent for publication of data related to this program.
: The authors declare no competing interests.
